These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 20118961)

  • 1. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.
    Cao Y
    Nat Rev Drug Discov; 2010 Feb; 9(2):107-15. PubMed ID: 20118961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and obesity.
    Lijnen HR
    Cardiovasc Res; 2008 May; 78(2):286-93. PubMed ID: 18006485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice.
    Bråkenhielm E; Cao R; Gao B; Angelin B; Cannon B; Parini P; Cao Y
    Circ Res; 2004 Jun; 94(12):1579-88. PubMed ID: 15155527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular targeting of adipose tissue as an anti-obesity approach.
    Daquinag AC; Zhang Y; Kolonin MG
    Trends Pharmacol Sci; 2011 May; 32(5):300-7. PubMed ID: 21349592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginseng treatment reverses obesity and related disorders by inhibiting angiogenesis in female db/db mice.
    Lee H; Kim M; Shin SS; Yoon M
    J Ethnopharmacol; 2014 Sep; 155(2):1342-52. PubMed ID: 25072361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue angiogenesis in obesity.
    Lemoine AY; Ledoux S; Larger E
    Thromb Haemost; 2013 Oct; 110(4):661-8. PubMed ID: 23595655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity.
    Lijnen HR; Frederix L; Van Hoef B
    Obesity (Silver Spring); 2010 Dec; 18(12):2241-6. PubMed ID: 20094042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis as a therapeutic target for obesity and metabolic diseases.
    Cao Y
    Chem Immunol Allergy; 2014; 99():170-9. PubMed ID: 24217609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid attenuates adipose tissue angiogenesis and insulin resistance in high fat diet-fed middle-aged mice via a sirt1-dependent mechanism.
    Luo X; Jia R; Yao Q; Xu Y; Luo Z; Luo X; Wang N
    Mol Nutr Food Res; 2016 Apr; 60(4):871-85. PubMed ID: 26750093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Angiogenesis agents.
    Marcinkiewicz C
    Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
    [No Abstract]   [Full Text] [Related]  

  • 12. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
    Singh JP
    Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic targets for potential disorders.
    Bhadada SV; Goyal BR; Patel MM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory roles of G-protein coupled receptors in adipose tissue metabolism and their therapeutic potential.
    Im H; Park JH; Im S; Han J; Kim K; Lee YH
    Arch Pharm Res; 2021 Feb; 44(2):133-145. PubMed ID: 33550564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose targets for obesity drug development.
    Boss O; Bergenhem N
    Expert Opin Ther Targets; 2006 Feb; 10(1):119-34. PubMed ID: 16441232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-angiogenic herbal extracts Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris suppresses adipogenesis in 3T3-L1 adipocytes.
    Hong Y; Kim MY; Yoon M
    Pharm Biol; 2011 Aug; 49(8):775-83. PubMed ID: 21449830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic nanotherapy for the control of obesity.
    Kajimoto K; Hossen MN; Harashima H
    Nanomedicine (Lond); 2013 May; 8(5):671-3. PubMed ID: 23656260
    [No Abstract]   [Full Text] [Related]  

  • 19. Adipose tissue mass can be regulated through the vasculature.
    Rupnick MA; Panigrahy D; Zhang CY; Dallabrida SM; Lowell BB; Langer R; Folkman MJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10730-5. PubMed ID: 12149466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning.
    Seki T; Hosaka K; Fischer C; Lim S; Andersson P; Abe M; Iwamoto H; Gao Y; Wang X; Fong GH; Cao Y
    J Exp Med; 2018 Feb; 215(2):611-626. PubMed ID: 29305395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.